Novo Nordisk A/S: CHMP recommends EU approval of Wegovy®
Wegovy® 7.2 mg in a single-dose pen has now been recommended by CHMP for approval in the EUNovo…
Oral Wegovy Wins EMA Panel Backing, Yet Novo Nordisk Shares Remain Under Pressure
EMA recommends first oral GLP-1 obesity pill for EU approval, but Novo Nordisk shares tumble 15% YTD amid…
Novo Nordisk’s Wegovy Wins EMA Flexibility In GLP-1 Access Push
Find your next quality investment with Simply Wall St’s easy and powerful screener, trusted by over 7 million…
Novo Nordisk’s European Logistics Breakthrough Meets US Pricing Headwinds
EMA relaxes Wegovy cold-chain rules, cutting EU distribution costs. Novo faces 2026 sales decline from US pricing pressure…